Myasthenia gravis (MG) treatment has entered an era of targeted therapies. Different targeted therapies take effect in various aspects of pathogenic mechanisms in MG. For a steady long-term control of MG symptoms. immunotherapies that reduce the production of pathogenic autoantibodies should be used. https://www.footballmediaservices.com/product-category/sawblade/